• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ANR

ANATARA LIFESCIENCES LTD - Announcements

0.00% ! 1.0¢
Market Cap $3.159M  !
Healthcare Biotechnology
Add to My Watchlist

Anatara Lifesciences Ltd is an Australia-based company focused on developing oral... Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements



Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
refresh Created with Sketch. REFRESH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.159M
Open High Low Volume
0.0¢ 0.0¢ 0.0¢ 0
Last trade - 08.51am 03/08/2026 (20 minute delay) ?
ANR (ASX) Chart
Day chart unavailable

Top Stories

AFT Pharmaceutical's multi-billion R&D opportunity

Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor Economist Stephen Koukoulas breaks down Michele Bullock's RBA legacy so far and what her final years as Governor could mean for Aussies.
Prairie Lithium advances towards first production as commercial DLE unit arrives Prairie Lithium (ASX:PL9) has reached a major milestone in its path to first production, with North America’s largest commercial Direct Lithium Extraction (DLE) unit now delivered to site in Saskatchewan. The arrival marks the start of installation as the ASX-listed company moves ...
Diablo expands critical minerals footprint at Star Range Welcome to HotCopper’s latest Watchlist, where this week we’ve been joined by Diablo Resources (ASX:DBO) CEO Lyle Thorne to discuss recent exploration that’s @expanded the scale” at Star Range in Beaver County, Utah.Listen to t...
Klevo Rewards advances stablecoin strategy with credit licence acquisition Klevo Rewards CEO Alexander Gold talks to HotCopper about officially completing the acquisition of an Australian credit licence.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.